ArticleBMJ case reports2023

Partial response in non-resectable adenosquamous carcinoma of the pancreas with high tumour mutation burden treated with gemcitabine, nab-paclitaxel and pembrolizumab.

Rodrigo Paredes de la Fuente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.